What's new

Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised

Apr 4, 2025 - 11:01
 0
Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Alstom invests over EUR 150 million to expand production in France

Next Article

Human medicines European public assessment report (EPAR): Vildagliptin / Metform...

Related Posts

Union product database: webinar for veterinary marketing authorisation holders on an industry dedicated read API, Online, from 27 February 2025, 11:00 (CET) to 27 February 2025, 12:00 (CET)

Union product database: webinar for veterinary marketin...

Feb 27, 2025  0

Veterinary medicines safety day: Adverse event reportin...

Apr 8, 2025  0

Product-information (QRD) templates - Human

Product-information (QRD) templates - Human

Apr 14, 2025  0